Stem Cells and Treatment of Neurodegenerative Disorders
Tobi L Limke, National Institute on Aging, Baltimore, Maryland, USA
Mahendra S Rao, National Institute on Aging, Baltimore, Maryland, USA
Published online: September 2005
Cell‐based therapy using neural stem and progenitor cells offers great hope for treating neurodegenerative diseases, including
Parkinson and Huntington diseases. Therapeutic strategies include cell replacement through transplantation of exogenous cells,
cell replacement through mobilization of endogenous cells and delivery of therapeutic agents through transplantation of genetically
Keywords: neural stem cell; neural progenitor cell; Parkinson disease; Huntington disease; Alzheimer disease; amyotrophic lateral sclerosis
Brundin P et al.
Neural transplantation for the treatment of Parkinson's disease.
Bjorklund A and
Cell replacement therapies for central nervous system disorders.
Hauser RA et al.
Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology.
Proceedings of the National Academy of Sciences of the USA
Hof PR and
Functional Neurobiology of Aging. San Diego, CA: Academic Press.
Rao MS and
Grafted lineage‐restricted precursors differentiate exclusively into neurons in the adult spinal cord.
Versatile cells against intractable diseases.
Shamblott MJ et al.
Human embryonic germ cell derivatives facilitate motor recovery of rats with diffuse motor neuron injury.
Journal of Neuroscience
Limke TL and
Neural stem cell therapy in the aging brain: pitfalls and possibilities.
Journal of Hematotherapy and Stem Cell Research
Tabar V and
Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats.